Focus Groups, Program Evaluation, and the Poor

Focus groups are a qualitative research technique which can be applied to program evaluation with low income clients. Focus groups are relatively easy to organize and operate, can be less expensive than other research techniques, can provide quick feedback, and possess the potential to empower low income clients. This paper discusses the development of focus groups, their strengths and weaknesses, and their utility in program evaluation. An example of their use in the evaluation of a state low income energy program is provided along with some guidelines for their use with low income respondents

Focus Groups, Program Evaluation, and the Poor

Focus groups are a qualitative research technique which can be applied to program evaluation with low income clients. Focus groups are relatively easy to organize and operate, can be less expensive than other research techniques, can provide quick feedback, and possess the potential to empower low income clients. This paper discusses the development of focus groups, their strengths and weaknesses, and their utility in program evaluation. An example of their use in the evaluation of a state low income energy program is provided along with some guidelines for their use with low income respondents

Hybrid solutions to the feature interaction problem

In this paper we assume a competitive marketplace where the features are developed by different enterprises, which cannot or will not exchange information. We present a classification of feature interaction in this setting and introduce an on-line technique which serves as a basis for the two novel <i>hybrid</i> approaches presented. The approaches are hybrid as they are neither strictly off-line nor on-line, but combine aspects of both. The two approaches address different kinds of feature interactions, and thus are complimentary. Together they provide a complete solution by addressing interaction detection and resolution. We illustrate the techniques within the communication networks domain

Discovering Homecare Services

Future homecare networks will consist of a very wide range of embedded services and software that will often rely on numerous other components to achieve their tasks. They will rarely operate in a self sufficient manner. The ability to discover and use services is not however a trivial task. Services may provide raw data, such as temperature readings, or higher contextual data, such as user activity and availability. Networks may change over time and may not be subject to a single management regime, implying the need for a great deal of self-reliance for any software component seeking services from elsewhere within the network. This chapter describes work carried out at the University of Stirling to improve service discovery and allow it to operate effectively in networks with a significant turnover in services. Simple syntactical keyword lookups are insufficient, and so semantics are introduced into the discovery process by using ontologies. However ontologies are known to grow and change over time and so maintaining them can be difficult and error-prone. The described approach employs a hierarchical approach that fosters re-use and sharing of ontologies to alleviate some of the more acute problems of building and maintaining large ontologies

Production of mutations in the white-spore strain

Production of mutations in the white-spore strai

Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki

Malaria is of continuing concern in nonimmune traveling populations. Traditionally, antimalarial drugs have been developed as agents for dual indications (treatment and prophylaxis). However, since 2000, when the 5th Amendment to the Declaration of Helsinki (DH2000) was adopted, development of new malaria prophylaxis drugs in this manner has ceased. As a consequence, there may not be any new drugs licensed for this indication in the foreseeable future. Major pharmaceutical companies have interpreted DH2000 to mean that the traditional development paradigm may be considered unethical because of doubt over the likelihood of benefit to endemic populations participating in clinical studies, the use of placebo, and the sustainability of post-trial access to study medications. In this article, we explore the basis of these concerns and suggest that the traditional development paradigm remains ethical under certain circumstances. We also consider alternative approaches that may be more attractive to sponsors as they either do not use placebo, or utilize populations in endemic countries who may unambiguously benefit. These approaches represent the way forward in the future, but are at present unproven in clinical practice, and face numerous regulatory, logistical and technical challenges. Consequently, in the short term, we argue that the traditional clinical development paradigm remains the most feasible approach and is ethical and consistent with the spirit of DH2000 under the appropriate circumstances